The Harvard-MIT Biomedical Engineering Center (BMEC) is an interdisciplinary collaboration between Harvard and MIT that focuses on biomedical engineering education, research, innovation, industry partnerships, and international talent exchange. The BMEC aims to advance human health through academic excellence in education and research that integrates science, engineering and medicine. It provides students and researchers access to world-class resources at both universities and at Harvard Medical School's teaching hospitals to facilitate cross-disciplinary collaborations and leverage multiple institutions' strengths. As a result, the BMEC has achieved numerous top publications, awards, patents, and funding and has developed technologies and treatments that improve patient care.
Engaging multidisciplinary teams in translational research and quality improv...Cancer Institute NSW
The Sydney West Translational Cancer Research Centre is a five year program grant funded by the Cancer Institute NSW aimed at improving patient outcomes through translational research. Multidisciplinary teams (MDTs) are key to the delivery of cancer care in Australia. There is a lack of knowledge and research into how these MDT teams can best be engaged in translational research from basic science through to implementation science and quality improvement.
The M+Visión Fellowship in Translational Biomedical Imaging is a program that leverages the resources of research communities in Madrid and Boston. The multidisciplinary fellowship is flexible, focused on important medical problems, and designed by the fellows. Program components include short courses, lecture series, rotations in clinical departments, and a 1-2 year research project. Applications are due February 15, 2013.
Oscar R Miranda CV 2015 A, Faculty PositionOscar1Miranda2
Oscar R. Miranda is a biomedical and pharmaceutical engineer with over 15 years of experience in research and development. He has a PhD in Chemistry from the University of Massachusetts-Amherst and is currently a post-doctoral associate at MIT. His research focuses on developing drug delivery systems, biomaterials, and cell therapies to treat diseases like arthritis, diabetes, and cancer. He has authored over 44 publications and invented 2 patents.
Oscar R Miranda CV 2015 A, Faculty PositionOscar1Miranda2
Oscar R. Miranda is a biomedical and pharmaceutical engineer with over 15 years of experience in research and development. He has extensive experience in areas such as drug delivery, biomaterials, cell therapy, biosensing, and translational medicine. His research focuses on developing tools to better understand, diagnose, image, and treat diseases using molecular and bioengineering approaches. He has a strong publication record, multiple patents, and has received several prestigious awards and grants for his work.
Oscar R Miranda CV 2015 A, Faculty PositionOscar1Miranda2
Oscar R. Miranda is a biomedical and pharmaceutical engineer with over 15 years of experience in research and development. He has extensive experience in areas such as drug delivery, biomaterials, cell therapy, biosensing, and translational medicine. His research focuses on developing tools to better understand, diagnose, image, and treat diseases using molecular and bioengineering approaches. He has a strong publication record, multiple patents, and has received several prestigious awards and grants.
Oscar R Miranda CV 2015 A, Faculty PositionOscar1Miranda2
Oscar Miranda is a senior biomedical and pharmaceutical engineer at MIT with over 15 years of experience in research and development. His research focuses on developing drug delivery systems, biomaterials, and cell therapies to treat diseases like arthritis, diabetes, and cancer. He has a strong publication record, multiple patents, and has received several prestigious awards and grants for his work.
The Harvard-MIT Biomedical Engineering Center (BMEC) is an interdisciplinary collaboration between Harvard and MIT that focuses on biomedical engineering education, research, innovation, industry partnerships, and international talent exchange. The BMEC aims to advance human health through academic excellence in education and research that integrates science, engineering and medicine. It provides students and researchers access to world-class resources at both universities and at Harvard Medical School's teaching hospitals to facilitate cross-disciplinary collaborations and leverage multiple institutions' strengths. As a result, the BMEC has achieved numerous top publications, awards, patents, and funding and has developed technologies and treatments that improve patient care.
Engaging multidisciplinary teams in translational research and quality improv...Cancer Institute NSW
The Sydney West Translational Cancer Research Centre is a five year program grant funded by the Cancer Institute NSW aimed at improving patient outcomes through translational research. Multidisciplinary teams (MDTs) are key to the delivery of cancer care in Australia. There is a lack of knowledge and research into how these MDT teams can best be engaged in translational research from basic science through to implementation science and quality improvement.
The M+Visión Fellowship in Translational Biomedical Imaging is a program that leverages the resources of research communities in Madrid and Boston. The multidisciplinary fellowship is flexible, focused on important medical problems, and designed by the fellows. Program components include short courses, lecture series, rotations in clinical departments, and a 1-2 year research project. Applications are due February 15, 2013.
Oscar R Miranda CV 2015 A, Faculty PositionOscar1Miranda2
Oscar R. Miranda is a biomedical and pharmaceutical engineer with over 15 years of experience in research and development. He has a PhD in Chemistry from the University of Massachusetts-Amherst and is currently a post-doctoral associate at MIT. His research focuses on developing drug delivery systems, biomaterials, and cell therapies to treat diseases like arthritis, diabetes, and cancer. He has authored over 44 publications and invented 2 patents.
Oscar R Miranda CV 2015 A, Faculty PositionOscar1Miranda2
Oscar R. Miranda is a biomedical and pharmaceutical engineer with over 15 years of experience in research and development. He has extensive experience in areas such as drug delivery, biomaterials, cell therapy, biosensing, and translational medicine. His research focuses on developing tools to better understand, diagnose, image, and treat diseases using molecular and bioengineering approaches. He has a strong publication record, multiple patents, and has received several prestigious awards and grants for his work.
Oscar R Miranda CV 2015 A, Faculty PositionOscar1Miranda2
Oscar R. Miranda is a biomedical and pharmaceutical engineer with over 15 years of experience in research and development. He has extensive experience in areas such as drug delivery, biomaterials, cell therapy, biosensing, and translational medicine. His research focuses on developing tools to better understand, diagnose, image, and treat diseases using molecular and bioengineering approaches. He has a strong publication record, multiple patents, and has received several prestigious awards and grants.
Oscar R Miranda CV 2015 A, Faculty PositionOscar1Miranda2
Oscar Miranda is a senior biomedical and pharmaceutical engineer at MIT with over 15 years of experience in research and development. His research focuses on developing drug delivery systems, biomaterials, and cell therapies to treat diseases like arthritis, diabetes, and cancer. He has a strong publication record, multiple patents, and has received several prestigious awards and grants for his work.
Oscar R Miranda CV 2015 A, Faculty PositionOscar1Miranda2
Oscar Miranda is a senior biomedical and pharmaceutical engineer at MIT with over 15 years of experience in research and development. His research focuses on drug delivery, biomaterials, cell therapy, and medical engineering. He has extensive experience developing drug delivery platforms, synthesizing nanoparticles, and engineering cells. Miranda has authored over 40 peer-reviewed publications and holds patents related to disease detection and treatment.
Oscar R Miranda CV 2015 A, Faculty PositionOscar1Miranda2
Oscar R. Miranda is a biomedical and pharmaceutical engineer with over 15 years of experience in research and development. He has extensive experience in areas such as drug delivery, biomaterials, cell therapy, bioengineering, and translational medicine. His research focuses on developing tools to better understand, diagnose, image, and treat diseases using molecular and bioengineering approaches. He has a strong publication record, multiple patents, and has received several prestigious awards and grants.
Oscar R Miranda CV 2015 A, Faculty PositionOscar1Miranda2
Oscar R. Miranda is a biomedical and pharmaceutical engineer with over 15 years of experience in research and development. He has extensive experience in areas such as drug delivery, biomaterials, cell therapy, biosensing, and translational medicine. His research focuses on developing tools to better understand, diagnose, image, and treat diseases using molecular and bioengineering approaches. He has authored over 40 peer-reviewed publications and holds patents related to biomedical devices and sensors.
Oscar R Miranda CV 2015 A, Faculty PositionOscar1Miranda2
Oscar R. Miranda is a biomedical and pharmaceutical engineer with over 15 years of experience in research and development. He has extensive experience in areas such as drug delivery, biomaterials, cell therapy, biosensing, and translational medicine. His research focuses on developing tools to better understand, diagnose, image, and treat diseases using molecular and bioengineering approaches. He has a strong publication record, including over 40 papers in high impact journals, and has received several prestigious awards and grants for his work.
Oscar R Miranda CV 2015 A, Faculty PositionOscar1Miranda2
Oscar R. Miranda is a biomedical and pharmaceutical engineer with over 15 years of experience in research and development. He has extensive experience in areas such as drug delivery, biomaterials, cell therapy, bioengineering, and translational medicine. His research focuses on developing tools to better understand, diagnose, image, and treat diseases using molecular and bioengineering approaches. He has a strong publication record, including over 40 papers in high impact journals, and has received several prestigious awards and grants for his work.
Oscar R Miranda CV 2015 A, Faculty PositionOscar1Miranda2
Oscar R. Miranda is a biomedical and pharmaceutical engineer with over 15 years of experience in research and development. He has a PhD in Chemistry/Nanotechnology from the University of Massachusetts-Amherst and is currently a postdoctoral associate at MIT. His research interests include drug delivery, biomaterials, cell therapy, and translational medicine. He has authored over 44 publications and invented 2 patents. His objective is to develop molecular and bioengineering tools to diagnose and treat diseases like arthritis, diabetes, and cancer.
Oscar R Miranda CV 2015 A, Faculty PositionOscar1Miranda2
This document provides a 3-page curriculum vitae for Oscar R. Miranda, a Senior Biomedical & Pharmaceutical Engineer at MIT. The summary includes his educational background, work experience, research interests, publications, patents, awards, and skills. He has over 15 years of experience in biomedical research and drug delivery, including positions at MIT, Harvard, UMass-Amherst, and Villanova University. His research focuses on developing new drug delivery systems, biomaterials, and cell therapies to treat diseases like cancer, diabetes, and arthritis.
Oscar R Miranda CV 2015 A, Faculty PositionOscar1Miranda2
This document provides a 3-page curriculum vitae for Oscar R. Miranda, a Senior Biomedical & Pharmaceutical Engineer at MIT. It summarizes his educational background which includes a PhD in Chemistry/Nanotechnology from UMass-Amherst and postdoctoral research at Harvard. It also outlines his extensive experience in areas such as drug delivery, biomaterials, cell therapy, and bioengineering. Finally, it lists his publications, patents, awards, and professional affiliations.
Oscar R Miranda CV 2015 A, Faculty PositionOscar1Miranda2
Oscar R. Miranda is a biomedical and pharmaceutical engineer with over 15 years of experience in research and development. He has expertise in areas such as drug delivery, biomaterials, cell therapy, bio-medical engineering, and translational medicine. Currently, he is a post-doctoral associate at MIT where he is developing biomedical devices and portable biomarker detection devices. He has a PhD in Chemistry/Nanotechnology from UMass-Amherst and extensive experience leading research projects and managing teams.
Oscar R Miranda CV 2015 A, Faculty PositionOscar1Miranda2
Oscar R. Miranda is a biomedical and pharmaceutical engineer with over 15 years of experience in research and development. He has a PhD in Chemistry/Nanotechnology from the University of Massachusetts-Amherst and is currently a post-doctoral associate at MIT. His research interests include drug delivery, biomaterials, cell therapy, and translational medicine. He has authored over 44 publications and invented 2 patents. His objective is to develop molecular and bioengineering tools to diagnose and treat diseases such as arthritis, diabetes, and cancer.
The IEEE Engineering in Medicine and Biology Society (EMBS) provides resources for students interested in bioengineering. It has over 10,000 members across 161 chapters globally. The EMBS mission is to advance biomedical engineering applications and provide leadership. Resources for students include funding for chapter activities, paper competitions, summer schools, and awards. The most important resource for students is their time to explore and connect within the EMBS community.
DESIGNING A CAREER IN BIOMEDICAL ENGINEERING- MUBESABrian Matovu
Discover your potential and ability by trying to venture into the field of biomedical engineering. It doesn't matter what profession your doing but what matters is how much you want to do and help about the current health problems in the country.
Enjoy the presentation on designing a career in Biomedical Engineering.
The Engineering in Medicine and Biology Society of the IEEE advances the application of engineering sciences and technology to medicine and biology, promotes the profession, and provides global leadership for the benefit of its members and humanity by disseminating knowledge, setting standards, fostering professional development, and recognizing excellence.
This document discusses biomedical engineering. It provides information about the Universidad politécnica de Sinaloa instructor Miguel Antonio Arriaga and his English class with students Perez Garcia Allfadir Raziel, Miriam Lorely Hurtado Chiñas, and Sergio Lizárraga Peraza in the biomedical engineering career program. Biomedical engineering applies engineering principles to medicine, with activities including designing medical devices, equipment, and technologies to help with diagnosis, therapy, and hospital administration. It combines engineering expertise with medical needs. Areas of biomedical engineering knowledge include biomagnetism, biomedical imaging, biomaterials, biomechanics, medical instrumentation, and more. Biomedical engineers work in research, hospital
A Recommendation To Biomedical Engineering Students From The EditorDon Dooley
The author discusses his recommendation that biomedical engineering students join a professional society like IEEE EMBS in order to promote lifelong learning. He argues that ABET accreditation requires demonstrating lifelong learning and membership in a professional society is one way to measure this. The author also states that he will no longer write recommendation letters for students who are not members of a professional biomedical engineering society. He believes this will encourage students to stay engaged with the field after graduation. The author welcomes feedback on this proposed change to his recommendation letter policy.
This document provides an overview of career prospects in biomedical engineering. It discusses the fields of biomedical engineering and clinical engineering. Some specialties within biomedical engineering include biomaterials, biomechanics, bio signal processing, medical imaging, and nanotechnology. After completing a B.Tech, career opportunities exist in hospitals, medical device companies, public sector organizations, and starting one's own business. Higher studies can be pursued in India or abroad. Research funding is available from government agencies. Overall, biomedical engineering is a fast-growing field with promising career prospects.
This document provides an overview of career prospects in biomedical engineering. It discusses the fields of biomedical engineering and clinical engineering. Some specialties within biomedical engineering include biomaterials, biomechanics, bio signal processing, medical imaging, and nanotechnology. After completing a B.Tech, career opportunities exist in hospitals, medical device companies, public sector organizations, and starting one's own business. Higher studies can be pursued in India or abroad. Research funding is available from government agencies. Overall, biomedical engineering is a fast-growing field with promising career prospects.
The document provides an overview of the life sciences industry in the North of England. It highlights that the North of England has 15 highly ranked universities and over 600 life sciences companies. It is home to world-class biomedical companies and has a large skilled workforce in science and technology. The region has strong research capabilities, including the UK Centre for Tissue Engineering and the National Biomanufacturing Centre. Manchester in particular has strengths in cancer research through institutions like the Christie Hospital NHS Trust and Manchester Cancer Research Centre.
The GSMA represents over 800 mobile operators and 200 associate members across 219 countries. It aims to drive growth in the mobile industry through innovation. There are already over 500 mHealth deployments worldwide, especially in Asia, Africa, and Europe. The GSMA's mission is to reduce healthcare costs and improve patient care through accelerating the deployment of scalable and interoperable mobile health solutions.
The document discusses shifting trends in mobile platforms and their implications for mHealth. It notes that smartphones have reached 50% market share in major markets and that 84% of US doctors will have smartphones by 2011. It analyzes usage and market shares of platforms like iOS, Android, Windows Phone and Blackberry. It also discusses design trends in consumer mobile apps that will influence mHealth apps and challenges of user retention for mobile apps.
More Related Content
Similar to Balcells, Mercedes - Innovation at MIT: Examples of translational research and internationalization
Oscar R Miranda CV 2015 A, Faculty PositionOscar1Miranda2
Oscar Miranda is a senior biomedical and pharmaceutical engineer at MIT with over 15 years of experience in research and development. His research focuses on drug delivery, biomaterials, cell therapy, and medical engineering. He has extensive experience developing drug delivery platforms, synthesizing nanoparticles, and engineering cells. Miranda has authored over 40 peer-reviewed publications and holds patents related to disease detection and treatment.
Oscar R Miranda CV 2015 A, Faculty PositionOscar1Miranda2
Oscar R. Miranda is a biomedical and pharmaceutical engineer with over 15 years of experience in research and development. He has extensive experience in areas such as drug delivery, biomaterials, cell therapy, bioengineering, and translational medicine. His research focuses on developing tools to better understand, diagnose, image, and treat diseases using molecular and bioengineering approaches. He has a strong publication record, multiple patents, and has received several prestigious awards and grants.
Oscar R Miranda CV 2015 A, Faculty PositionOscar1Miranda2
Oscar R. Miranda is a biomedical and pharmaceutical engineer with over 15 years of experience in research and development. He has extensive experience in areas such as drug delivery, biomaterials, cell therapy, biosensing, and translational medicine. His research focuses on developing tools to better understand, diagnose, image, and treat diseases using molecular and bioengineering approaches. He has authored over 40 peer-reviewed publications and holds patents related to biomedical devices and sensors.
Oscar R Miranda CV 2015 A, Faculty PositionOscar1Miranda2
Oscar R. Miranda is a biomedical and pharmaceutical engineer with over 15 years of experience in research and development. He has extensive experience in areas such as drug delivery, biomaterials, cell therapy, biosensing, and translational medicine. His research focuses on developing tools to better understand, diagnose, image, and treat diseases using molecular and bioengineering approaches. He has a strong publication record, including over 40 papers in high impact journals, and has received several prestigious awards and grants for his work.
Oscar R Miranda CV 2015 A, Faculty PositionOscar1Miranda2
Oscar R. Miranda is a biomedical and pharmaceutical engineer with over 15 years of experience in research and development. He has extensive experience in areas such as drug delivery, biomaterials, cell therapy, bioengineering, and translational medicine. His research focuses on developing tools to better understand, diagnose, image, and treat diseases using molecular and bioengineering approaches. He has a strong publication record, including over 40 papers in high impact journals, and has received several prestigious awards and grants for his work.
Oscar R Miranda CV 2015 A, Faculty PositionOscar1Miranda2
Oscar R. Miranda is a biomedical and pharmaceutical engineer with over 15 years of experience in research and development. He has a PhD in Chemistry/Nanotechnology from the University of Massachusetts-Amherst and is currently a postdoctoral associate at MIT. His research interests include drug delivery, biomaterials, cell therapy, and translational medicine. He has authored over 44 publications and invented 2 patents. His objective is to develop molecular and bioengineering tools to diagnose and treat diseases like arthritis, diabetes, and cancer.
Oscar R Miranda CV 2015 A, Faculty PositionOscar1Miranda2
This document provides a 3-page curriculum vitae for Oscar R. Miranda, a Senior Biomedical & Pharmaceutical Engineer at MIT. The summary includes his educational background, work experience, research interests, publications, patents, awards, and skills. He has over 15 years of experience in biomedical research and drug delivery, including positions at MIT, Harvard, UMass-Amherst, and Villanova University. His research focuses on developing new drug delivery systems, biomaterials, and cell therapies to treat diseases like cancer, diabetes, and arthritis.
Oscar R Miranda CV 2015 A, Faculty PositionOscar1Miranda2
This document provides a 3-page curriculum vitae for Oscar R. Miranda, a Senior Biomedical & Pharmaceutical Engineer at MIT. It summarizes his educational background which includes a PhD in Chemistry/Nanotechnology from UMass-Amherst and postdoctoral research at Harvard. It also outlines his extensive experience in areas such as drug delivery, biomaterials, cell therapy, and bioengineering. Finally, it lists his publications, patents, awards, and professional affiliations.
Oscar R Miranda CV 2015 A, Faculty PositionOscar1Miranda2
Oscar R. Miranda is a biomedical and pharmaceutical engineer with over 15 years of experience in research and development. He has expertise in areas such as drug delivery, biomaterials, cell therapy, bio-medical engineering, and translational medicine. Currently, he is a post-doctoral associate at MIT where he is developing biomedical devices and portable biomarker detection devices. He has a PhD in Chemistry/Nanotechnology from UMass-Amherst and extensive experience leading research projects and managing teams.
Oscar R Miranda CV 2015 A, Faculty PositionOscar1Miranda2
Oscar R. Miranda is a biomedical and pharmaceutical engineer with over 15 years of experience in research and development. He has a PhD in Chemistry/Nanotechnology from the University of Massachusetts-Amherst and is currently a post-doctoral associate at MIT. His research interests include drug delivery, biomaterials, cell therapy, and translational medicine. He has authored over 44 publications and invented 2 patents. His objective is to develop molecular and bioengineering tools to diagnose and treat diseases such as arthritis, diabetes, and cancer.
The IEEE Engineering in Medicine and Biology Society (EMBS) provides resources for students interested in bioengineering. It has over 10,000 members across 161 chapters globally. The EMBS mission is to advance biomedical engineering applications and provide leadership. Resources for students include funding for chapter activities, paper competitions, summer schools, and awards. The most important resource for students is their time to explore and connect within the EMBS community.
DESIGNING A CAREER IN BIOMEDICAL ENGINEERING- MUBESABrian Matovu
Discover your potential and ability by trying to venture into the field of biomedical engineering. It doesn't matter what profession your doing but what matters is how much you want to do and help about the current health problems in the country.
Enjoy the presentation on designing a career in Biomedical Engineering.
The Engineering in Medicine and Biology Society of the IEEE advances the application of engineering sciences and technology to medicine and biology, promotes the profession, and provides global leadership for the benefit of its members and humanity by disseminating knowledge, setting standards, fostering professional development, and recognizing excellence.
This document discusses biomedical engineering. It provides information about the Universidad politécnica de Sinaloa instructor Miguel Antonio Arriaga and his English class with students Perez Garcia Allfadir Raziel, Miriam Lorely Hurtado Chiñas, and Sergio Lizárraga Peraza in the biomedical engineering career program. Biomedical engineering applies engineering principles to medicine, with activities including designing medical devices, equipment, and technologies to help with diagnosis, therapy, and hospital administration. It combines engineering expertise with medical needs. Areas of biomedical engineering knowledge include biomagnetism, biomedical imaging, biomaterials, biomechanics, medical instrumentation, and more. Biomedical engineers work in research, hospital
A Recommendation To Biomedical Engineering Students From The EditorDon Dooley
The author discusses his recommendation that biomedical engineering students join a professional society like IEEE EMBS in order to promote lifelong learning. He argues that ABET accreditation requires demonstrating lifelong learning and membership in a professional society is one way to measure this. The author also states that he will no longer write recommendation letters for students who are not members of a professional biomedical engineering society. He believes this will encourage students to stay engaged with the field after graduation. The author welcomes feedback on this proposed change to his recommendation letter policy.
This document provides an overview of career prospects in biomedical engineering. It discusses the fields of biomedical engineering and clinical engineering. Some specialties within biomedical engineering include biomaterials, biomechanics, bio signal processing, medical imaging, and nanotechnology. After completing a B.Tech, career opportunities exist in hospitals, medical device companies, public sector organizations, and starting one's own business. Higher studies can be pursued in India or abroad. Research funding is available from government agencies. Overall, biomedical engineering is a fast-growing field with promising career prospects.
This document provides an overview of career prospects in biomedical engineering. It discusses the fields of biomedical engineering and clinical engineering. Some specialties within biomedical engineering include biomaterials, biomechanics, bio signal processing, medical imaging, and nanotechnology. After completing a B.Tech, career opportunities exist in hospitals, medical device companies, public sector organizations, and starting one's own business. Higher studies can be pursued in India or abroad. Research funding is available from government agencies. Overall, biomedical engineering is a fast-growing field with promising career prospects.
The document provides an overview of the life sciences industry in the North of England. It highlights that the North of England has 15 highly ranked universities and over 600 life sciences companies. It is home to world-class biomedical companies and has a large skilled workforce in science and technology. The region has strong research capabilities, including the UK Centre for Tissue Engineering and the National Biomanufacturing Centre. Manchester in particular has strengths in cancer research through institutions like the Christie Hospital NHS Trust and Manchester Cancer Research Centre.
Similar to Balcells, Mercedes - Innovation at MIT: Examples of translational research and internationalization (20)
The GSMA represents over 800 mobile operators and 200 associate members across 219 countries. It aims to drive growth in the mobile industry through innovation. There are already over 500 mHealth deployments worldwide, especially in Asia, Africa, and Europe. The GSMA's mission is to reduce healthcare costs and improve patient care through accelerating the deployment of scalable and interoperable mobile health solutions.
The document discusses shifting trends in mobile platforms and their implications for mHealth. It notes that smartphones have reached 50% market share in major markets and that 84% of US doctors will have smartphones by 2011. It analyzes usage and market shares of platforms like iOS, Android, Windows Phone and Blackberry. It also discusses design trends in consumer mobile apps that will influence mHealth apps and challenges of user retention for mobile apps.
This document summarizes a conference on trends in mobile health (mHealth) held on May 25, 2012 in Barcelona. The conference featured presentations from experts on mHealth trends globally and in Spain. It also included a debate on how mHealth is evolving from pilots to mainstream applications and the challenges of interoperability, scalability, and sustainability of mHealth initiatives. The floor was then opened for further debate.
The document discusses challenges facing health systems, including an aging population with multiple chronic conditions, rising costs, and technological advances. It focuses on reforms to improve coordination within and outside of hospitals to better manage chronic diseases. This includes strengthening primary care, public health interventions, and aligning payment systems to prioritize prevention and care outside of hospitals when possible. The goal is to improve outcomes and make more efficient use of resources.
Albert Laszlo Barabasi - Innovation inspired positive change in health careponencias_mihealth2012
This document summarizes network medicine and its applications. It discusses how human diseases can be modeled and studied as complex networks. Disease genes are found to cluster together in protein interaction networks, forming disease modules. Mapping disease genes onto interactome networks can help identify new candidate genes and delineate disease modules. Validation using various biological data shows the predicted disease genes are statistically associated with the disease. Mapping asthma genes in this way identified a statistically significant disease module within the first 200 prioritized genes. Network medicine approaches provide a framework for understanding the molecular basis of diseases.
Este documento describe la posibilidad de realizar tratamientos de rehabilitación en el hogar del paciente mediante el uso de videoconsolas y juegos. La telerehabilitación permite programar y controlar ejercicios de rehabilitación de forma remota para complementar los tratamientos presenciales. El proyecto Play for Health utiliza una videoconsola para diseñar juegos de rehabilitación específicos que estimulan la movilidad y cognición del paciente, permitiendo al equipo clínico realizar un seguimiento remoto.
Moya, Francesc - Mapa de Tendencias: Encuesta sobre el uso de las TIC en Salu...ponencias_mihealth2012
El documento describe la Encuesta sobre el Uso de las TIC en Salud en Cataluña. Se realiza desde 2007 para conocer el estado de las tecnologías de la información y comunicación en el sector salud de Cataluña y orientar las decisiones estratégicas. La encuesta recoge datos sobre plataformas tecnológicas, sistemas de información, tratamiento de la información clínica, conectividad e interoperabilidad, seguridad y gestión de las TIC. Los resultados se comparten con los proveedores de salud para que puedan compararse y conoc
Martinez, Elena - Escola de Salut de la Barceloneta. Un proyecto para el empo...ponencias_mihealth2012
Este documento describe el proyecto "Escola de Salut de la Barceloneta", cuyo objetivo es proporcionar más autonomía a las personas mayores e involucrar a la población en la gestión del sistema sanitario. El proyecto involucra a varias organizaciones comunitarias y ofrece talleres sobre temas de salud, nutrición y envejecimiento para empoderar a los participantes. El proyecto evalúa continuamente su organización, programa y docentes para mejorar continuamente.
Lukacs, Eloi - Exercise is Medicine: possible everywhere with mywellness keyponencias_mihealth2012
This document discusses the benefits of exercise for health and introduces the mywellness key and portal as tools for evaluating patient habits, prescribing customized exercise programs, motivating and educating patients, and remotely monitoring their progress. It also notes that physical activity levels can impact obesity rates around the world and provides contact information for the key account manager at Technogym.
El proyecto ComPENSA tuvo como objetivo principal desarrollar un modelo para reducir el consumo innecesario de antibióticos mediante intervenciones dirigidas al personal sanitario y pacientes en un área sanitaria integrada que incluye 254.000 habitantes. El proyecto implementó actividades formativas y de comunicación durante varios años y logró reducir el consumo de antibióticos en un 6%, disminuyendo la dosis diaria definida de 24,23 a 22,82 entre los períodos pre- y post-proyecto.
Escudero, Joan - Chronic disease management for Diabetes. Sucessful integrati...ponencias_mihealth2012
The document discusses integrating the private telemedicine service Medical Guard into Catalunya's public Personal Health Folder initiative. Medical Guard allows close monitoring of diabetic patients by collecting blood glucose readings via mobile devices and the internet. Integrating it into the Personal Health Folder will give diabetic citizens access to the service directly through their public health profile. This public-private partnership combines advanced private technologies with public health initiatives to improve care for chronic conditions like diabetes.
De Haro, Andreu - Proyecto e-learning aplicado en el Hospital Universitario V...ponencias_mihealth2012
El Hospital Universitario Vall d'Hebron implementó un proyecto de aprendizaje electrónico (e-learning) para mejorar la formación de su personal. Crearon una plataforma de formación en línea propia para proporcionar una oferta formativa más accesible y actualizada. La plataforma se utilizó para impartir una sesión sobre cateterización de vías periféricas a 1.240 profesionales, lo que resultó en una reducción del 56,25% de las bacteriemias asociadas y ahorros económicos de entre 126.865
Closa, Conxita - Transformación de la medicina y de los servicios sanitariosponencias_mihealth2012
La plataforma interactiva de rehabilitación propone un modelo innovador de terapia combinada que incluye tanto controles presenciales como trabajo en línea para optimizar los recursos y atender a más pacientes. El programa ofrece sesiones presenciales iniciales seguidas de sesiones en línea con controles virtuales del tutor, con el objetivo de que los pacientes adquieran progresivamente un mayor grado de conocimiento sobre su condición hasta convertirse en "pacientes expertos".
Atienza, Carlos - Experiencias empresariales en desarrollo de tecnología sani...ponencias_mihealth2012
El documento describe cómo la empresa Gasmedi pasó de ser un proveedor de servicios de terapias respiratorias a domicilio a ser también un fabricante de productos sanitarios. Con la colaboración del Instituto de Biomecánica de Valencia, Gasmedi desarrolló una nueva máscara para el tratamiento de la apnea del sueño aplicando un modelo de innovación abierta que implicó a usuarios, centros de investigación y fabricantes. El nuevo diseño de máscara mejora los problemas de usabilidad y riesgos para la salud de los modelos existentes.
Garcia, Joaquin - Tratamiento preventivo de enfermos crónicos con ayuda de la...ponencias_mihealth2012
El documento describe el proyecto Sophi@, un programa de coaching para pacientes crónicos en Francia que combina factores tecnológicos y humanos. El proyecto incluye la segmentación de pacientes, modelos predictivos, acompañamiento a través de plataformas digitales y asesores de salud, con el objetivo de mejorar la calidad de vida y ahorrar recursos sanitarios.
The document discusses using an open innovation network to manage ideas and innovation projects across multiple hospitals and provider groups. It introduces Induct Software, an innovation management platform that can help establish such a network. Induct allows hospitals to capture ideas from various stakeholders, manage innovation projects and portfolios, and facilitate collaboration both within and outside each organization through an open innovation portal. The document provides examples of how Induct has helped healthcare innovation consortiums like CIMIT to connect researchers, hospitals and funders.
Sitjar, Salvador - Proyecto sobre un nuevo modelo de autogestión profesional ...ponencias_mihealth2012
Este documento describe un proyecto de autogestión profesional en atención primaria implementado en el CAP Les Corts de Barcelona. El proyecto GAPI otorgó autonomía a los profesionales para organizar su trabajo y evaluó resultados entre 2008-2011, mostrando mejoras como una reducción del 27.7% en visitas presenciales, un aumento del 652.7% en atención no presencial, y una reducción del 9.5% en gastos de farmacia. El modelo GAPI demostró ser más eficiente que el modelo organizativo tradicional
Sanchez, Miquel - Reorganización de un área de Urgencias por niveles de urgen...ponencias_mihealth2012
La reorganización del área de urgencias del Hospital Clínic de Barcelona por niveles de urgencia en lugar de por especialidades redujo el tiempo de espera de los pacientes en un 22,8%, la estancia total en urgencias en un 11,1% y permitió atender un 7,6% más de pacientes diarios, todo ello con los mismos recursos humanos y espacios. Además, disminuyó la tasa de pacientes que abandonaban el área un 18,8% y las reclamaciones un 50%. La conclusión es que esta organización por niveles de urgencia es
Pascual, Josep - Network de atención a crónicos como práctica innovadora en a...ponencias_mihealth2012
Este documento describe el modelo de atención a pacientes crónicos de SARquavitae en Barcelona. El modelo incluye 49 centros residenciales para mayores, 10 centros de atención a discapacitados, 59 centros de día y 3 viviendas con servicios. Atienden a más de 200,000 personas al año con 12,200 empleados y 11,300 camas. El modelo se basa en la detección temprana, prevención, planificación anticipada y coordinación de recursos a través de una red para proporcionar una mejor calidad de vida y ser
Nuño, Roberto - Programa de estratificación poblacional en el País Vascoponencias_mihealth2012
Este documento describe el programa de estratificación poblacional implementado en el País Vasco. El programa clasifica a todos los ciudadanos basado en su riesgo de consumo de recursos de salud, identificando pacientes con enfermedades crónicas o en riesgo. El programa ha permitido mejorar la atención a pacientes crónicos de manera proactiva mediante programas diferenciados y la identificación de pacientes para intervenciones específicas. La estratificación complementa el criterio clínico y permite dirigir mejor los esfuerzos
Lecture 6 -- Memory 2015.pptlearning occurs when a stimulus (unconditioned st...AyushGadhvi1
learning occurs when a stimulus (unconditioned stimulus) eliciting a response (unconditioned response) • is paired with another stimulus (conditioned stimulus)
Travel Clinic Cardiff: Health Advice for International TravelersNX Healthcare
Travel Clinic Cardiff offers comprehensive travel health services, including vaccinations, travel advice, and preventive care for international travelers. Our expert team ensures you are well-prepared and protected for your journey, providing personalized consultations tailored to your destination. Conveniently located in Cardiff, we help you travel with confidence and peace of mind. Visit us: www.nxhealthcare.co.uk
Travel vaccination in Manchester offers comprehensive immunization services for individuals planning international trips. Expert healthcare providers administer vaccines tailored to your destination, ensuring you stay protected against various diseases. Conveniently located clinics and flexible appointment options make it easy to get the necessary shots before your journey. Stay healthy and travel with confidence by getting vaccinated in Manchester. Visit us: www.nxhealthcare.co.uk
Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdfOsvaldo Bernardo Muchanga
GASTROINTESTINAL INFECTIONS AND GASTRITIS
Osvaldo Bernardo Muchanga
Gastrointestinal Infections
GASTROINTESTINAL INFECTIONS result from the ingestion of pathogens that cause infections at the level of this tract, generally being transmitted by food, water and hands contaminated by microorganisms such as E. coli, Salmonella, Shigella, Vibrio cholerae, Campylobacter, Staphylococcus, Rotavirus among others that are generally contained in feces, thus configuring a FECAL-ORAL type of transmission.
Among the factors that lead to the occurrence of gastrointestinal infections are the hygienic and sanitary deficiencies that characterize our markets and other places where raw or cooked food is sold, poor environmental sanitation in communities, deficiencies in water treatment (or in the process of its plumbing), risky hygienic-sanitary habits (not washing hands after major and/or minor needs), among others.
These are generally consequences (signs and symptoms) resulting from gastrointestinal infections: diarrhea, vomiting, fever and malaise, among others.
The treatment consists of replacing lost liquids and electrolytes (drinking drinking water and other recommended liquids, including consumption of juicy fruits such as papayas, apples, pears, among others that contain water in their composition).
To prevent this, it is necessary to promote health education, improve the hygienic-sanitary conditions of markets and communities in general as a way of promoting, preserving and prolonging PUBLIC HEALTH.
Gastritis and Gastric Health
Gastric Health is one of the most relevant concerns in human health, with gastrointestinal infections being among the main illnesses that affect humans.
Among gastric problems, we have GASTRITIS AND GASTRIC ULCERS as the main public health problems. Gastritis and gastric ulcers normally result from inflammation and corrosion of the walls of the stomach (gastric mucosa) and are generally associated (caused) by the bacterium Helicobacter pylor, which, according to the literature, this bacterium settles on these walls (of the stomach) and starts to release urease that ends up altering the normal pH of the stomach (acid), which leads to inflammation and corrosion of the mucous membranes and consequent gastritis or ulcers, respectively.
In addition to bacterial infections, gastritis and gastric ulcers are associated with several factors, with emphasis on prolonged fasting, chemical substances including drugs, alcohol, foods with strong seasonings including chilli, which ends up causing inflammation of the stomach walls and/or corrosion. of the same, resulting in the appearance of wounds and consequent gastritis or ulcers, respectively.
Among patients with gastritis and/or ulcers, one of the dilemmas is associated with the foods to consume in order to minimize the sensation of pain and discomfort.
Co-Chairs, Val J. Lowe, MD, and Cyrus A. Raji, MD, PhD, prepared useful Practice Aids pertaining to Alzheimer’s disease for this CME/AAPA activity titled “Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neuroradiology in Diagnosis and Treatment.” For the full presentation, downloadable Practice Aids, and complete CME/AAPA information, and to apply for credit, please visit us at https://bit.ly/3PvVY25. CME/AAPA credit will be available until June 28, 2025.
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdfrightmanforbloodline
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7shruti jagirdar
Unit 4: MRA 103T Regulatory affairs
This guideline is directed principally toward new Molecular Entities that are
likely to have significant use in the elderly, either because the disease intended
to be treated is characteristically a disease of aging ( e.g., Alzheimer's disease) or
because the population to be treated is known to include substantial numbers of
geriatric patients (e.g., hypertension).
Nano-gold for Cancer Therapy chemistry investigatory projectSIVAVINAYAKPK
chemistry investigatory project
The development of nanogold-based cancer therapy could revolutionize oncology by providing a more targeted, less invasive treatment option. This project contributes to the growing body of research aimed at harnessing nanotechnology for medical applications, paving the way for future clinical trials and potential commercial applications.
Cancer remains one of the leading causes of death worldwide, prompting the need for innovative treatment methods. Nanotechnology offers promising new approaches, including the use of gold nanoparticles (nanogold) for targeted cancer therapy. Nanogold particles possess unique physical and chemical properties that make them suitable for drug delivery, imaging, and photothermal therapy.
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
How to Control Your Asthma Tips by gokuldas hospital.Gokuldas Hospital
Respiratory issues like asthma are the most sensitive issue that is affecting millions worldwide. It hampers the daily activities leaving the body tired and breathless.
The key to a good grip on asthma is proper knowledge and management strategies. Understanding the patient-specific symptoms and carving out an effective treatment likewise is the best way to keep asthma under control.
Know the difference between Endodontics and Orthodontics.Gokuldas Hospital
Your smile is beautiful.
Let’s be honest. Maintaining that beautiful smile is not an easy task. It is more than brushing and flossing. Sometimes, you might encounter dental issues that need special dental care. These issues can range anywhere from misalignment of the jaw to pain in the root of teeth.
Balcells, Mercedes - Innovation at MIT: Examples of translational research and internationalization
1. Harvard-MIT Biomedical Engineering Center
Innovation at MIT:
The Center,
What is Examples of translational research
unique
about it?
- Education
and internationalization
- Research Mercedes Balcells, PhD
- Industry
- International Research
MIT Scientist, Harvard-MIT Biomedical Engineering Center
Professora Titular, Institut Químic de Sarrià
77 Massachusetts Avenue E25-438 | Cambridge MA 02139 USA
1
2. Harvard-MIT Biomedical Engineering Center
FROM
3. Hosting 1-2 international students at MIT
FROM TO
1. Studying structure-function Pervasis, Inc
(Cambridge, US)
?
relationship in a blood vessel
A
Medical device
engineering
(stents, sensors,
2. Studying mechanotransduction balloons…)
pathways
C D
(Barcelona, Spain)
TO
A MIT-Spain
77 Massachusetts Avenue E25-438 | Cambridge MA 02139 USA
2
3. Harvard-MIT Biomedical Engineering Center
What we have learned:
• Train students to carry their engineering and scientific expertise from the
laboratory bench to the patient's bedside and to bring clinical insights from the
patient's bedside to the laboratory bench.
• Establish partnerships that facilitate collaborations across disciplines and
leverage the strengths of multiple institutions.
• A change in paradigm - from “pure” research to innovation - requires
developing an innovation ecosystem that promotes entrepreneurship; this does
not happen in a year or two.
• Internationalize, internationalize, internationalize
77 Massachusetts Avenue E25-438 | Cambridge MA 02139 USA
3
4. Harvard-MIT Biomedical Engineering Center
• Advance human health through academic excellence
in education and research that integrates science,
engineering and medicine.
• Educate outstanding minds, cultivate leaders, create
knowledge, and generate cost-effective preventative,
diagnostic, and therapeutic innovations.
77 Massachusetts Avenue E25-438 | Cambridge MA 02139 USA
4
5. Harvard-MIT Biomedical Engineering Center
EDUCATION
MD, PhD Programs
Harvard
Train students to carry their
engineering and scientific
expertise from the laboratory
US Harvard-MIT
bench to the patient's bedside
Academia BMEC and to bring clinical insights from
the patient's bedside to the
US MIT laboratory bench.
Hospitals
40MD, 15PhD, 5MD/PhD, 5MBA
“teaches you how medical doctors
think and how they talk”
Kay Furman, HST PhD candidate
77 Massachusetts Avenue E25-438 | Cambridge MA 02139 USA
5
6. Harvard-MIT Biomedical Engineering Center
RESEARCH
Harvard Investigators have special access
to both universities' world-class
resources and to Harvard Medical
School's teaching hospitals.
US Harvard-MIT
BMEC This partnership facilitates
Academia
collaborations across disciplines
US and leverages the strengths of
MIT
Hospitals multiple institutions.
As a result, our researchers
accomplish more than they could
independently.
77 Massachusetts Avenue E25-438 | Cambridge MA 02139 USA
6
7. Harvard-MIT Biomedical Engineering Center
TISSUE ENGINEERED ENDOTHELIAL CELLS
Allogeneic EC
CELL NUMBER/105
10
8
6
4
1 x 4 x 0.3cm3
Matrix 2
0 0 7 14
TIME (days)
Viability Assay
Viability
Ox-LDL
AcLDL Uptake
77 Massachusetts Avenue E25-438 | Cambridge MA 02139 USA
7
8. Harvard-MIT Biomedical Engineering Center
STRUCTURE/FUNCTION RELATIONSHIP
Intima (Endothelium)
Connective tissue
Media (Smooth Muscle)
VASCULAR REPAIR
Adventitia (Fibroblasts)
Paracrine regulation
of arterial repair in vivo
Ox-LDL
Viability
77 Massachusetts Avenue E25-438 | Cambridge MA 02139 USA
8
9. Harvard-MIT Biomedical Engineering Center
MECHANOTRANSDUCTION
ENVIRONMENT MATTERS
77 Massachusetts Avenue E25-438 | Cambridge MA 02139 USA
9
11. Harvard-MIT Biomedical Engineering Center
ACHIEVEMENTS
Smart hardware
EKG, monitors
Harvard Intensive care unit medicine
Space medicine
Software
Hospital and clinical
Harvard-MIT
Integrated functional biology
BMEC Devices
Drugs
US MIT Gene therapy
Hospitals US Tissue and cell engineering
Industry
77 Massachusetts Avenue E25-438 | Cambridge MA 02139 USA
11
12. Harvard-MIT Biomedical Engineering Center
“MIT INNOVATION ECOSYSTEM”
SEBC
Enterprise MIT Sloan
I-Teams Forum
Academia
$700 million
VCPE 100K
research/year competition
Enterpreneurship
Deshpande Center
Center
Industry
MIT TLO
MIT VMS
Commercial
Enterprise
77 Massachusetts Avenue E25-438 | Cambridge MA 02139 USA
12
13. Harvard-MIT Biomedical Engineering Center
Deshpande Center (2002)
• Gift of $17.5MM from Desh and
Jaishree Deshpande
• Have raised additional $4MM since
from donors, corporations
• Grants: - 500 proposals
- 72 projects
- $11+MM grants
• Results: - 200+ faculty/students
- 100+ volunteers (catalyst program)
- 22 start-ups + 1 license
- Capital >$180 MM
77 Massachusetts Avenue E25-438 | Cambridge MA 02139 USA
13
14. Harvard-MIT Biomedical Engineering Center
Spinouts
Active Spectrum Test Equipment
Beam Power Amplifiers for Wireless
Brontes(3M) Dental Imaging
ERC Titanium production
Entra Drug delivery
Hepregen Drug Discovery
Molecular Stamping Nano Production
Myomo Stroke Rehabilitation
Pervasis Tissue Repair
Pufco Secure Processors
QD vision Displays
Sentina Auto Sensors
Taris Biomedical Drug Delivery
1366 Solar Cells
Vertica Database Software
77 Massachusetts Avenue E25-438 | Cambridge MA 02139 USA
14
15. Harvard-MIT Biomedical Engineering Center
“MIT INNOVATION ECOSYSTEM”
SEBC
Enterprise MIT Sloan
I-Teams Forum
Academia
$700 million
International? VCPE
International?
100K
research/year competition
Enterpreneurship
Deshpande Center
Center
Industry
MIT TLO
MIT VMS
International? International? Commercial
Enterprise
77 Massachusetts Avenue E25-438 | Cambridge MA 02139 USA
15
16. MISTI
MISTI – MIT
International Science
and Technology
Initiatives - is MIT's
primary international
program.
MISTI connects MIT
students and faculty
with research and
innovation around the
world.
MIT International Science and Technology Initiatives
17. MISTI
network in Brazil China
14 countries Switzerland
Chile
Spain
Russia France
Mexico Germany
Korea India
Japan Italy Israel
19. Harvard-MIT Biomedical Engineering Center
Today MIT-Spain is
5.5 1 4 170 14 55 18 70
years partner sponsors “host” events projects professors visitors
321 14
STRATEGIC PARTNER
La Cambra de Barcelona
MIT-SPAIN
SPONSORS
HOST INSTITUTIONS Fundació Empreses IQS
La Cambra de Barcelona
(~50) La Caixa
Posimat
77 Massachusetts Avenue E25-438 | Cambridge MA 02139 USA
19
20. Harvard-MIT Biomedical Engineering Center
Brigham and Women’s Hospital
Prof. Vacanti
Harvard-MIT Biomedical Engineering
Center Agata Gelabertó
Prof. Edelman, Dr. Balcells Albert Milé
- Boston - Sant Joan de Déu
Dr. Claveria/Dr. Parri
- Barcelona -
The Vanderbilt
Bill
Wilkerson
Center
Dr. Eavey
- Nashville-
77 Massachusetts Avenue E25-438 | Cambridge MA 02139 USA
20
21. Harvard-MIT Biomedical Engineering Center
What we have learned:
• Train students to carry their engineering and scientific expertise from the
laboratory bench to the patient's bedside and to bring clinical insights from the
patient's bedside to the laboratory bench.
• Establish partnerships that facilitate collaborations across disciplines and
leverage the strengths of multiple institutions.
• A change in paradigm - from “pure” research to innovation - requires
developing an innovation ecosystem that promotes entrepreneurship; this does
not happen in a year or two.
• Internationalize, internationalize, internationalize
77 Massachusetts Avenue E25-438 | Cambridge MA 02139 USA
21
22. Harvard-MIT Biomedical Engineering Center
This work has been possible thanks to the support from
Ministerio de Ciencia e Innovación (BFU2009--‐09804)
The Barcelona Chamber of Commerce
Fundació Empreses Institut Químic de Sarrià
Posimat
Special thanks to
MIHealth Committee and Fira de Barcelona
… and an open invitation to collaborate with us
77 Massachusetts Avenue E25-438 | Cambridge MA 02139 USA
22